Corvus Pharmaceuticals, Inc. - Special Call Transcript
Can everyone take their seat? I think you can perhaps make me live now as opposed to -- I got a mic here. There's plenty room down in the front, if you would like. So we're live? Okay. Great.
Thank you all for coming tonight. I know it's Friday night and you're delaying your dinner for a short time to hear about Corvus. We presented 2 really interesting presentations today that I want to review with you. This meeting is webcast, so I also appreciate the people staying up, listening to us online. Appreciate that attention.
We're very pleased to have with us this evening. Dr. Jason Luke from the University of Pittsburgh, who just delivered a marvelous paper just a couple of hours ago, an oral presentation on our anti-CD73 antibody called CPI-006, which I'll get back to in a second.
We also have members of the Corvus team here, Dr. Mehrdad Mobasher, our CMO; Dr. Suresh Mahabhashyam, our Clinical Director; Stephen Willingham, our -- I don't call him Doctor, Dr. Stephen
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |